Epilepsy Trial, Recruiting NCT07605858 Sponsor: Hospices Civils de Lyon Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT07605858
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 55 years old
  • People who have been diagnosed with epilepsy that originates in the temporal or frontal lobe of the brain, based on non-surgical testing
  • People whose epilepsy has not been adequately controlled by medication, as defined by the International League Against Epilepsy guidelines
  • People who are already scheduled to undergo a specific type of brain monitoring procedure called SEEG (where small electrodes are placed in the brain to locate the source of seizures)
  • People whose SEEG procedure will include at least one electrode in the frontal lobe and one in the temporal lobe
  • People who are enrolled in the French public health system
  • People who are able to understand and agree to take part in the study, and are able to follow the study requirements

Who may not be able to join:

  • People whose epilepsy originates from multiple areas of the brain rather than a single location
  • People who have severe obstructive sleep apnea (where breathing repeatedly stops during sleep) that has not been treated
  • People whose SEEG brain recordings are too disrupted to allow sleep stages to be identified during the study procedure
  • People with serious difficulties with thinking, memory, or understanding that would prevent them from fully participating in the study
  • People with an unstable mental health condition
  • People who are currently participating in another interventional research study that has an exclusion period that has not yet ended
  • People who are under a court or government order restricting their freedom
  • People who are under a legal protection arrangement such as guardianship or curatorship
  • People who are not covered by the French social security system or an equivalent scheme

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 (0) 4 72 35 70 44

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 June 2028

Where this trial is recruiting

🇫🇷 France 🇺🇸 United States

Primary endpoints

Rate of arousal or awakening following DES

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov